Certara, Inc.(CERT)

Description: Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

---

Keywords: Biopharmaceutical Life Sciences Medication Pharmacy Health Sciences Pharmacology Drug Discovery Pharmaceutical Sciences Drug Development Systems Biology

---

Home Page: www.certara.com

CERT Technical Analysis

100 Overlook Center
Princeton, NJ 08540
United States
Phone: 609 716 7900

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)